Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2241

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292241)

Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets with strengths 40 mg, 5 mg, and 25 mg respectively. The label indicates the product is a film-coated tablet, prescription only, packaged as 30 tablets. It is manufactured by Par Pharmaceutical and relabeled by Bryant Ranch Prepack, featuring the NDC 63629-2241-1.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure of olmesartan medoxomil, one of the active ingredients in the combination tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure of the active ingredients olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide as a molecular diagram depicting atom connectivity and functional groups.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure diagram depicting the molecular structure of the active ingredient in olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide combination tablet. The diagram shows connected atoms and bonds characteristic of olmesartan medoxomil's chemical composition.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

A line chart featuring multiple data series comparing baseline and various combinations of olmesartan medoxomil and hydrochlorothiazide doses. The x-axis represents time or sequence intervals, and the y-axis shows a numerical scale from 55 to 100, likely indicating measured response values across treatments.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line chart titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour,' showing mean systolic blood pressure (mmHg) on the vertical axis versus hours post dose on the horizontal axis. It compares baseline and various treatment groups including AML 10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25, and OM40/HCTZ25 over a 24-hour period with separate lines for each treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.